Literature DB >> 31706805

Improved carotid intima-media thickness-induced high-intensity interval training associated with decreased serum levels of Dkk-1 and sclerostin in type 2 diabetes.

Alireza Ghardashi-Afousi1, Mohsen Davoodi2, Behnam Keshtkar- Hesamabadi3, Maryam Asvadi-Fard4, Mohammad Ali Babaee Bigi5, Mohammad Reza Izadi6, Abbas Ali Gaeini7.   

Abstract

AIMS: Carotid intima-media thickness (cIMT) is a validated surrogate marker of atherosclerosis. Dickkopf-1 (Dkk-1) and sclerostin modulate wingless signaling, which is involved in atherosclerosis. The purpose of this study was to investigate whether 12 weeks of high-intensity interval training (HIIT) would improve cIMT and serum Dkk-1 and sclerostin levels in patients with type 2 diabetes.
METHODS: Seventy-four sedentary patients with type 2 diabetes were randomly divided into HIIT and control groups. The HIIT group intervention was 6 intervals (4 min) at 85%-90% HRmax separated by 3 min at 45%-50% HRmax in 3 sessions/week for 12 weeks. Before and after the intervention, cIMT, artery diameter and wall/lm ratio were recorded with high-resolution ultrasound. Serum sclerostin and Dkk-1 were measured by enzyme-linked immunosorbent assay (ELISA).
RESULTS: cIMT decreased significantly in the HIIT group (0.83 ± 0.17 baseline, 0.71 ± 0.14 follow-up) compared to the control group (0.84 ± 0.20 baseline, 0.85 ± 0.19 follow-up) (P < .05). Dkk-1 and sclerostin decreased significantly after 12 weeks of HIIT (P < .01). In addition, VO2peak was increased in the HIIT group than the control group (by 6.2 mL/kg/min) (P < .05). There was a positive correlation between percent changes in cIMT and percent changes in Dkk-1 and sclerostin (both P < .01). Additionally, there were a negative correlation between percent changes VO2peak and cIMT (r = - 0.740, P = .003), Dkk-1 (r = - 0.844, P < .001) and sclerostin (r = - 0.575, P = .001) in HIIT group.
CONCLUSION: Our results indicate that HIIT decreases cIMT, serum levels of Dkk-1 and sclerostin and improves VO2peak in patients with type 2 diabetes.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Atherosclerosis; Carotid intima-media thickness; Dickkopf-1; High-intensity interval training; Sclerostin; Wingless pathway

Mesh:

Substances:

Year:  2019        PMID: 31706805     DOI: 10.1016/j.jdiacomp.2019.107469

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  6 in total

1.  Association of serum sclerostin and osteoprotegerin levels with the presence, severity and prognosis in patients with acute myocardial infarction.

Authors:  Xing Shui; Ruimin Dong; Zhen Wu; Zefeng Chen; Zheqi Wen; Leile Tang; Xujing Xie; Lin Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-05-11       Impact factor: 2.174

Review 2.  Role of myokines and osteokines in cancer cachexia.

Authors:  Fabrizio Pin; Lynda F Bonewald; Andrea Bonetto
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

Review 3.  Interactions between Muscle and Bone-Where Physics Meets Biology.

Authors:  Marietta Herrmann; Klaus Engelke; Regina Ebert; Sigrid Müller-Deubert; Maximilian Rudert; Fani Ziouti; Franziska Jundt; Dieter Felsenberg; Franz Jakob
Journal:  Biomolecules       Date:  2020-03-10

Review 4.  The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders.

Authors:  Yuichi Takashi; Daiji Kawanami
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

5.  Decreased Serum Dickkopf-1 Levels After Hypoglycemic Therapy in Patients with Type 2 Diabetes Mellitus.

Authors:  Fei Gao; Cheng Li; Jiahui Peng; Wei Lu; Wei Zhu; Jian Zhou; Jingyi Lu; Xiaojing Ma
Journal:  Diabetes Metab Syndr Obes       Date:  2022-09-05       Impact factor: 3.249

6.  The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up.

Authors:  Adam Kern; Tomasz Stompór; Jolanta Kiewisz; Bartłomiej E Kraziński; Jacek Kiezun; Marta Kiezun; Jerzy Górny; Ewa Sienkiewicz; Leszek Gromadziński; Dariusz Onichimowski; Jacek Bil
Journal:  J Pers Med       Date:  2021-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.